Neosense Technologies highlights catheter clinical success
The umbilical catheter enabled oxygen and temperature monitoring in a preterm infant, allowing removal after two days due to good vital signs.
See the latest news and media coverage for Neosense Technologies. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of continuous blood oxygen monitoring systems
neosen.seLast updated
The umbilical catheter enabled oxygen and temperature monitoring in a preterm infant, allowing removal after two days due to good vital signs.
The trial involves 75 preterm infants across five Stockholm/Uppsala hospitals to validate the umbilical catheter before audit and market launch.
The company's tailored umbilical catheter monitored oxygen and temperature in a preterm infant at Karolinska University Hospital after six years of development.
Representatives displayed products at the Joint European Neonatal Societies congress in Maastricht, receiving positive feedback from clinical users and business partners.
Track Neosense Technologies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Neosense Technologies and other trending companies.